Judge Clarifies Gilead Didn't Directly Infringe HIV Drug IP

By Gina Kim · May 9, 2024, 9:21 PM EDT

A Delaware federal judge on Thursday rejected Gilead Sciences' request to amend her judgment finding that two medications in its HIV prevention regimen, Truvada and Descovy, directly infringed the government's invalidated...

To view the full article, register now.